Correlation Between Kura Oncology and Spero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Kura Oncology and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kura Oncology and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kura Oncology and Spero Therapeutics, you can compare the effects of market volatilities on Kura Oncology and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kura Oncology with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kura Oncology and Spero Therapeutics.
Diversification Opportunities for Kura Oncology and Spero Therapeutics
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Kura and Spero is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Kura Oncology and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and Kura Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kura Oncology are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of Kura Oncology i.e., Kura Oncology and Spero Therapeutics go up and down completely randomly.
Pair Corralation between Kura Oncology and Spero Therapeutics
Given the investment horizon of 90 days Kura Oncology is expected to under-perform the Spero Therapeutics. In addition to that, Kura Oncology is 1.5 times more volatile than Spero Therapeutics. It trades about -0.12 of its total potential returns per unit of risk. Spero Therapeutics is currently generating about -0.04 per unit of volatility. If you would invest 144.00 in Spero Therapeutics on August 24, 2024 and sell it today you would lose (25.00) from holding Spero Therapeutics or give up 17.36% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.21% |
| Values | Daily Returns |
Kura Oncology vs. Spero Therapeutics
Performance |
| Timeline |
| Kura Oncology |
| Spero Therapeutics |
Kura Oncology and Spero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kura Oncology and Spero Therapeutics
The main advantage of trading using opposite Kura Oncology and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kura Oncology position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.| Kura Oncology vs. ZyVersa Therapeutics | Kura Oncology vs. Sonnet Biotherapeutics Holdings | Kura Oncology vs. Zura Bio Limited | Kura Oncology vs. Phio Pharmaceuticals Corp |
| Spero Therapeutics vs. Assembly Biosciences | Spero Therapeutics vs. Achilles Therapeutics PLC | Spero Therapeutics vs. Instil Bio | Spero Therapeutics vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |